HCP Live
Contagion LiveCGT LiveNeurology LiveHCP LiveOncology LiveContemporary PediatricsContemporary OBGYNEndocrinology NetworkPractical CardiologyRheumatology Netowrk

Addressing Issues Surrounding Current Antibiotic Development

James S. Lewis, PharmD, FIDSA, addresses the issues that surround current antibiotic development.

James S. Lewis, PharmD, FIDSA, Co-Director of Antibiotic Stewardship, Oregon Health and Science University, addresses the issues that surround current antibiotic development. The primary issue involves a common perception shared by some pharmaceutical companies regarding return on investment.

Related Content:

ID WeekVideosANTIBIOTICSHEALTHCARE-ASSOCIATED INFECTIONS (HAI)E. COLIPREVENTIONConferences
10 Years After HIV PrEP Approval, Uptake Lowest Among Highest Risk Groups
In Low-Income Communities, Pharmacists Can Play a Critical Role in Vaccine Access
Infectious Disease Virologist: “Nobody Should be Scared of Paxlovid Rebound”